Tort Reform and Personal Injury Litigation: Adapting Strategies and Tactics for Plaintiff and Defense Counsel

Mr. Campbell earned his J.D. from Harvard Law School in 2000, where he served on the Harvard Negotiation Law Review, the International Law Journal, and the Civil Rights-Civil Liberties Law Review and competed in the Ames Moot Court Competition. He received a B.S. in Philosophy and English from Austin Peay State University in 1997 and was named its Outstanding Young Alumnus of the Year in 2002. He is admitted to practice in Georgia and New York.

Mr. Campbell chairs DLA Piper's Product Liability and Mass Torts group, named Practice Group of the Year in 2025 by Law360, ranked Band 1 by Chambers, and ranked Tier 1 by The Legal 500, and he co-chairs the firm's Product Liability, Mass Torts & Class Actions group. He is ranked in Chambers USA for Nationwide Product Liability & Mass Torts, recognized by The Legal 500 as a leading lawyer in pharmaceutical and medical device defense, selected for inclusion in Best Lawyers for mass tort and product liability litigation, and recognized by Forbes as best in state in Georgia, the only product liability lawyer to receive that recognition in the state. His article on hindsight bias in failure-to-warn cases received the Defense Research Institute's G. Duffield Smith Outstanding Publication Award.

Mr. Campbell speaks frequently on evidence and expert issues, including as speaker for the myLawCLE program Digital Evidence at Trial, addressing impeachment strategy and admissibility before stepping into the courtroom, and as presenter on causation experts in products liability cases and admissibility takeaways from the Tylenol multidistrict litigation. He serves as Publications Vice-Chair of the DRI Drug and Medical Device Steering Committee, served on the Product Liability Editorial Board of Law360, and is a member of the American Bar Association, the New York State Bar Association, the Georgia Bar Association, the Defense Research Institute, Lawyers for Civil Justice, and the US Chamber of Commerce.

Mr. Campbell is lead global strategic and coordination attorney for Bayer in a mass tort involving a contraceptive medical device spanning five continents and more than a dozen countries, where the defense holds a near 100 percent success rate with more than 150 favorable findings by trial courts, appellate courts, and court-appointed experts, including a complete defense judgment after a class action trial in the Supreme Court of Victoria in Australia. He is national trial attorney for Hankook Tire and has tried the company's product liability cases in Arkansas, Missouri, North Carolina, Tennessee, and Virginia. He led Bayer's defense of the multidistrict litigation involving phenylephrine to a complete dismissal on federal preemption grounds, represents Pfizer in the Depo-Provera multidistrict litigation, and represents Novo Nordisk in a product liability litigation involving the alleged sharing of insulin pens by a Connecticut hospital. He also serves as lead national, strategic, and trial attorney in product liability, toxic tort, and class action matters across the automotive, industrial equipment, pharmaceutical, medical device, healthcare, consumer goods, and safety equipment industries.